Our Work
Podcasts
English
မြန်မာ
log in
Join Us
Donate
Director General of the Department of Medical Research Dr Zaw Than Tun, right, speaks at a conference on the use of convalescent plasma to treat COVID-19 on August 20, as Dr Rai Mra listens. (Nyein Su Wai Kyaw Soe | Frontier)
Director General of the Department of Medical Research Dr Zaw Than Tun, right, speaks at a conference on the use of convalescent plasma to treat COVID-19 on August 20, as Dr Rai Mra listens. (Nyein Su Wai Kyaw Soe | Frontier)

Experimental plasma treatment saves eight severe COVID-19 patients

Months before the US allowed the use of convalescent plasma in emergency COVID-19 care, Myanmar had already provided the treatment to eight patients.

Account Required

You must have an account to access this content.

Create Account

Already a member? Log in here

More stories

Related stories

Online,
in person,
in your inbox.

Want to make sense of what’s happening in Myanmar, regardless of where you live? Come join the conversation.
Sign Up Now

Become a Frontier Member

Support our independent journalism and get exclusive behind-the-scenes content and analysis.

Join Us

Keep your team in the loop

Take a a team membership today so that your organisation is always on top of the latest news from Myanmar.

Subscribe

Join the community

Sign up for Frontier Fridays, our free weekly round-up, and get access to one article a month on the Frontier website.